Selected References: Bro SP, et al. 2015. Adverse pregnancy outcomes after exposure to methylphenidate or atomoxetine during pregnancy. Clin Epidemiol; 7:139-47. Bröms G, et al. 2023. Atomoxetine in Early Pregnancy and the Prevalence of Major Congenital Malformations: A Multinational Study. J Clin Psychiatry 16, 84(1). Brown JT, et al. 2019. Clinical Pharmacogenetics Implementation Consortium Guideline for Cytochrome P450 (CYP)2D6 Genotype and Atomoxetine Therapy. Clin Pharmacol …
The Baby Blog
About Our Baby Blog
Every person wants to know what’s best for their baby, especially when it comes to knowing how to minimize exposure risks. Our relatable stories are packed with practical information from our rotating staff of MotherToBaby expert bloggers. Whatever topic you’re looking for, our blogs will provide you a great foundation to learn more.
Tildrakizumab (Ilumya®)
Selected References: English language version of Summary of Product Characteristics for Ilumetri (tildrakizumab) Accessed: https://www.ema.europa.eu/en/medicines/human/EPAR/ilumetri#product-information-section. Gisondi P, et al. 2022. Italian adaptation of EuroGuiDerm guideline on the systemic treatment of chronic plaque psoriasis. Ital J Dermatol Venerol. 157(Suppl. 1 to No. 1):1-78. Haycraft K, , et al. 2020. Outcomes of pregnancies from the tildrakizumab phase I–III clinical …
Critical Periods of Development
Selected References: Bleyl SB and Schoenwolf GC, 2010. What is the timeline of important events during pregnancy that may be disrupted by a teratogenic exposure? Teratology Primer, edited by Barbara Hales et al. The Teratology Society. Carlson BM, 2008. Human Embryology and Developmental Biology, 4th ed. St. Louis, MO: Elsevier-Health Sciences Division. Cochard LR, 2012. Netter’s Atlas of Human Embryology: Updated Edition. Teterboro, NJ: Icon Learning Systems. Moore KL et al, 2013. …
Thalidomide
Selected References Brooks C, et al. 1977. Linear growth of children with limb deformities following exposure to thalidomide in utero. Acta Paediatr Scan 66:673-675. Castilla E, et al. 1996. Thalidomide, a current teratogen in South America. Teratology 54:273-277. Gao S, et al. 2020. Recent advances in the molecular mechanism of thalidomide teratogenicity. Biomed Pharmacother. ;127:110114. doi: 10.1016/j.biopha.2020.110114. Epub 2020 Apr 15. Gollop T, et al. 1987. Prenatal …
Paroxetine
Selected References: Alwan S, et al. 2007. Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects. N Engl J Med 356(26):2684-2692. Andrade S, et al. 2009. Antidepressant use and risk of persistent pulmonary hypertension of the newborn. Pharmacoepidemiol Drug Saf 18(3):246-252. Berard A, et al. 2016. The risk of major cardiac malformations associated with paroxetine use during the first trimester of pregnancy: A systematic review and meta-analysis. …
